MU Stock Forecast: Why Micron Deserves A Price Target Of $115

motek 1The MU stock forecast was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology – Senior Analyst at I Know First.

Summary

  • Micron’s stock has risen +43% since my June 20, 2020 buy recommendation for it. I am again endorsing it as a buy. MU is still relatively undervalued.
  • Micron’s SGRAM memory products are key to Nvidia and AMD’s discrete GPU business. The discrete GPU business is growing at 33.6% CAGR.
  • The Piotroski score of MU is 8. Micron is a safe long-term investment.
  • Micron is expanding into the fast-growing $13.7 billion data center accelerator market. The scalable Micron AC-511 compute module product is very promising.

New forecasting serviceRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

MU Stock Forecast: Micron Deserves A 90-Day Price Target of $65

motek 1The article was written by Motek Moyen Research Seeking Alpha’s #1 Writer on Long Ideas and #2 in Technology – Senior Analyst at I Know First.

Summary:

  • Micron’s stock dipped more than 3% last Friday due to concerns over the new coronavirus outbreak in China.
  • In spite of this price decrease, MU still trades higher than $48.60. That was MU’s price during my last buy recommendation for it last September 26.
  • Micron’s new LPPDR5 for smartphones is now in mass production. Xiaomi’s Mi 10 and Mi 10 Pro will come equipped with Micron’s LPDDR5. Other 2020 phones will shortly follow.
  • LPDDR5 is 50% faster than LPPDR4x. It is also up to 30% more energy efficient. LPPDR5 will definitely become the new standard for smartphones and tablets this year.
  • In spite of the stock market’s anxiety over the new coronavirus outbreak, I Know First still is very bullish on Micron’s stock.

TSMC stock forecastRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

MU stock forecast: Virtuous Cycle In Data Economy Helps Micron Surge, But Cyclical Risk Remains Concerning

 

The article was written by Yutian Fang, Financial Analyst at I Know First and Master of Science in Finance candidate at Brandeis International Business School

MU stock forecast: Virtuous Cycle In Data Economy Helps Micron Surge, But Cyclical Risk Remains Concerning

 Summary:

  • Micron holds very competitive positions in both DRAM and NAND markets after series of acquisitions
  • The latest quarterly report demonstrated Micron’s strong profitability but the future growth would be impacted by the market demand and pricing dynamics
  • The company enjoys outstanding operating efficiency and financial health
  • The cyclical risk is still one of the major concerns from market and the stock price need adjustment for the confirmative ascending channel
  • Supported by I Know First Algorithm Forecast, currently my recommendation for MU is to hold in the short term

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

MU Stock Forecast: 45.99% Return In 3 Months

MU had a very strong signal of -98.40 and a predictability of 0.14. In accordance with the algorithm, the company reported short-term capital losses of -45.99%.

MU was part of the stock forecast that is found in the “Best Tech Stocks” Package.

The full Top 10 Tech Stocks forecast includes a daily prediction for a total of 20 stocks with bullish and bearish signals:

  • Top ten stocks picks to long
  • Top ten stocks picks to short

MU Stock Forecast

MU Stock Forecast: An Algorithmic Analysis

MU Stock Forecast

Micron Technology, Inc. (MU), based in Boise, Idaho, makes MU stock forecastdynamic random-access memory (DRAM), NAND flash memory chips, image sensors and other components, and memory modules. The stock was a huge winner in 2014, as the stock price increased nearly 60%, well above the average return for the S&P 500. However, the stock has struggled so far this year, with share prices falling more than 20%. The dip in the stock’s performance might not be done yet, either, as the company has forecasted lower than expected guidance for the current quarter, but a buying opportunity could present itself in the future for patient investors.